Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating Expenses
General and administrative	$ 319,435	$ 339,595	$ 885,870	$ 1,385,503
Research and development	325,685	216,840	1,048,081	847,335
Professional fees	5,073,658	454,940	5,672,598	1,053,498
Total Operating Expenses	5,718,778	1,011,375	7,606,549	3,286,336
Total Operating Loss	(5,718,778)	(1,011,375)	(7,606,549)	(3,286,336)
Other Income (Expense)	9,522	(1,237)	6,352	(8,105)
Net Loss	(5,709,256)	(1,012,612)	(7,600,197)	(3,294,441)
Net loss attributable to non-controlling interests	(3,141)		(4,795)
Net Loss attributable to CQENS Technologies Inc	$ (5,706,115)	$ (1,012,612)	$ (7,595,402)	$ (3,294,441)
Basic loss per common share	$ (0.21)	$ (0.04)	$ (0.29)	$ (0.13)
Diluted loss per common share	$ (0.21)	$ (0.04)	$ (0.29)	$ (0.13)
Basic weighted average shares outstanding	26,551,519	26,133,658	26,327,603	26,093,475
Diluted weighted average shares outstanding	26,551,519	26,133,658	26,327,603	26,093,475
Comprehensive Loss:
Change in foreign currency translation adjustments	$ (30)		$ (68)
Comprehensive Loss:	(5,706,145)	(1,012,612)	(7,595,470)	(3,294,441)
Comprehensive loss attributable to non-controlling interests	(15)		(34)
Comprehensive loss attributable to CQENS Technologies, Inc.	$ (5,706,130)	$ (1,012,612)	$ (7,595,436)	$ (3,294,441)